SBSB
GILD icon

Sullivan, Bruyette, Speros & Blaney’s Gilead Sciences GILD Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$337K Sell
5,220
-191
-4% -$12.3K 0.01% 224
2020
Q4 		$315K Buy
5,411
+131
+2% +$7.91K 0.01% 221
2020
Q3 		$334K Sell
5,280
-1,012
-16% -$70.2K 0.02% 189
2020
Q2 		$484K Sell
6,292
-2,211
-26% -$169K 0.03% 140
2020
Q1 		$636K Buy
8,503
+2,075
+32% +$143K 0.04% 106
2019
Q4 		$418K Sell
6,428
-130
-2% -$8.47K 0.02% 155
2019
Q3 		$416K Sell
6,558
-178
-3% -$11.6K 0.02% 151
2019
Q2 		$455K Buy
6,736
+959
+17% +$63.1K 0.03% 137
2019
Q1 		$376K Buy
5,777
+3
+0.1% +$199 0.02% 150
2018
Q4 		$361K Buy
5,774
+441
+8% +$30.8K 0.02% 136
2018
Q3 		$412K Sell
5,333
-66
-1% -$4.99K 0.04% 109
2018
Q2 		$382K Hold
5,399
– – 0.04% 114
2018
Q1 		$407K Sell
5,399
-774
-13% -$61.5K 0.04% 102
2017
Q4 		$442K Buy
6,173
+84
+1% +$6.38K 0.04% 101
2017
Q3 		$493K Sell
6,089
-5
-0.1% -$382 0.05% 89
2017
Q2 		$431K Sell
6,094
-453
-7% -$30.1K 0.04% 92
2017
Q1 		$445K Sell
6,547
-232
-3% -$16.3K 0.04% 86
2016
Q4 		$485K Buy
6,779
+42
+0.6% +$3.12K 0.05% 86
2016
Q3 		$533K Buy
6,737
+257
+4% +$20.9K 0.05% 75
2016
Q2 		$541K Buy
+6,480
New +$575K 0.06% 66

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sullivan, Bruyette, Speros & Blaney's GILD Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney reduced its Gilead Sciences (GILD) stake by 3.5% in Q1 2021, selling an estimated $12.3K and leaving 5,220 shares worth $337K. The position accounts for 0.01% of the portfolio, ranked #224.

Sullivan, Bruyette, Speros & Blaney first reported a position in GILD in Q2 2016 and has held it in 20 quarters since. The position peaked at $636K in Q1 2020. 1,568 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 5,220 shares of Gilead Sciences worth $337K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney sold 191 Gilead Sciences shares in Q1 2021, an estimated $12.3K.
  • Gilead Sciences made up 0.01% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #224 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Gilead Sciences in Q2 2016 and has held it in 20 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Gilead Sciences position peaked at $636K in Q1 2020.
  • 1,568 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.